NIH-funded research NIH-funded research

Detecting early aging in people with schizophrenia

Official title: Towards Developing Biomarkers for Premature Aging in Schizophrenia

Funded at Brigham and Women's Hospital · NIH-11195241 · Data updated 2026-11-12

This work looks for blood and brain markers that show early aging in people with schizophrenia.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2023
Project endDecember 31, 2028
Funding year2025
Award (this year)$249,000
NIH project number4R00MH131850-03
Project IDNIH-11195241 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be people diagnosed with schizophrenia, especially early in illness, who can provide blood samples and participate in cognitive testing and brain scans.

Less likely to help

People without schizophrenia or those unable or unwilling to undergo blood draws or MRI scans are unlikely to be included or benefit directly from this work.

What this research studies

Researchers will analyze existing clinical, cognitive, blood, and brain imaging data from people with schizophrenia and matched healthy volunteers across the lifespan. They will measure proteins linked to cellular aging (senescence-associated secretory phenotype, SASP) in blood and relate those levels to physical health, thinking skills, and brain structure using MRI and diffusion imaging. The initial phase uses data from 80 people with early schizophrenia and 80 matched healthy controls, with plans to extend the approach to larger datasets. The aim is to find measurable biomarkers that could help detect and monitor premature aging in people with schizophrenia.

Why it matters

Potential benefit: If successful, this could lead to tests that identify and track premature aging in people with schizophrenia and help guide treatments to protect brain and body health.

How similar studies have gone: Prior studies have reported signs of accelerated aging in schizophrenia, but linking blood SASP proteins to brain imaging and clinical measures is a relatively new approach with limited clinical validation so far.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Seitz-Holland, Johanna — Brigham and Women's Hospital
  • Study coordinator: Seitz-Holland, Johanna

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.